Novavax Says Its Updated COVID-19 Vaccine Generated Immune Response Against Eris Subvariant

Reuters (8/22, Mandowara) reports, “Novavax Inc said on Tuesday its updated protein-based COVID-19 vaccine generated an immune response against emerging forms of coronavirus such as the ‘Eris’ subvariant in small studies in animals.” Eris, or EG.5, “accou...